Transvaginal radiofrequency to treat vaginal symptoms of menopause

Transvaginal radiofrequency to treat geniturinary syndrome of Menopause: Randomized Clinical Trial

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

REBEC

Registry ID

RBR-2g42hz7

Enrollment

Registered

2026-02-12

Start date

2026-03-01

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrophic vaginitis

Interventions

After the initial assessment (first consultation), participants will return for a second consultation, during which the proposed intervention will begin. They will be divided into a Control Group and

s own software), for a period of 3 weeks, totaling 3 sessions. During the radiofrequency application, the participant will be in the gynecological position, and the transducer will be introduced vagin

Eligibility

Sex/Gender

Female

Age

30 Years to No maximum

Inclusion criteria

Inclusion criteria: Menopause. Diagnosis of geniturinary síndrome of menopause

Exclusion criteria

Exclusion criteria: Previous pelvic radiotheray. Women using pacemaker

Design outcomes

Primary

Measure	Time frame
A 50% improvement is expected in the Vaginal Health Index, which is related to vaginal atrophy.	—

Secondary

Measure	Time frame
A 40% improvement in satisfaction with sexual function is expected	—

Countries

Brazil

Contacts

Public ContactLucas Schreiner

Pontifícia Universidade Católica do Rio Grande do Sul

schreinerlucas@hotmail.com+55(51)33205179

Outcome results

None listed

Source: REBEC (via WHO ICTRP) · Data processed: Mar 14, 2026